Our study compares the effectiveness and molecular mechanisms involved in the antiproliferative effects of the TK inhibitors, nilotinib and imatinib, as individual therapeutic agents or in combination with DXR, in human cell lines of STS, being susceptible to development of drug resistance. Here, TKT is linked to telomere syndrome.